1. Turkish Journal of Pathology (
http://www.turkjpath.org)
(ISSN: 1018-5615) is the official journal of the Federation of
Turkish Pathology Societies. The journal is a peer-reviewed
scientific journal published every four months, three times a
year (January, May, September), and aims to reach all relevant
national and international medical institutions and persons
in printed and electronic versions free of charge. Articles in
Turkish and English are welcomed.
2. Turkish Journal of Pathology is devoted to the continuing
education of national and international practicing pathologists,
and to provide a forum for social and scientific communication
in the field. Studies that emphasize these aims provide the basis
of publication, including original articles, case reports, reviews,
abstracts from annual meetings, letters to editor, book reviews,
biographies, and articles on social issues. Turkish Journal of
Pathology accepts only invited review articles.
3. A submitted article must be an original contribution not
previously published (except as an abstract or a preliminary
report), must not be under consideration for publication
elsewhere, and, if accepted, must not be published elsewhere in
similar form in any languages. Articles presented at a meeting
or symposium are accepted if this is stated.
4.
SCIENTIFIC RESPONSIBILITY
Authors are responsible for their articles' conformity to
scientific rules. Each person listed as an author is expected to
have participated in the study to a significant extent. The order
of the authors' names must be a joint decision. Authors must
sign the author name order in the
copyright transfer form. All
authors' names must be included under the article's title. Any
individual who does not meet the criteria for authorship but has
contributed to the article can be listed in "Acknowledgement(s)"
section.
5.
ETHICAL RESPONSIBILITY
Authors are responsible for their articles' conformity to
ethical rules. The study protocol for human experimentation
must conform the ethical guidelines established in the World
Medical Association Declaration of Helsinki (
http://www.wma.net/e/policy/b3.htm). Therefore, all articles submitted for
publication must specify that the ethic standards of the above
committee were adhered. Any necessary permission documents
from local and international ethic committees must also be sent
with the article. Authors must specify in the method(s) section
that they performed the study according to these principles and
that they obtained "informed consent" from their institution's
ethic committees and the participants.
Articles reporting the results of experimental studies on animals
must include a statement that study protocol was approved by
the animal ethics committee of relevant institution and that the
study was conducted in accordance with "Guide for the Care and
Use of Laboratory Animals" (
http://www.nap.edu/catalog/5140.html). Authors are strongly requested to send an approval of the
relevant ethics committee.
If any previously published quoted passages, tables, figures, etc.
are used in the article, authors should obtain written permission
from publication rights holders, and should specify this in the
article.
Authors must specify in the references page that they have no
commercial relations or, if present, the nature of the relation
(consultancy, other agreements) with commercial products or
drugs used in their study or with any pharmaceutical companies
or with companies providing financial sponsorship for the
article.
The editors and publisher assume no responsibility regarding
features and explanations of any commercial products advertised
in the journal.
The confidentiality and privacy of patients and study
participants:
Authors should avoid descriptive information such as patient
names, initials, reference numbers or photographs to appear
in their article. Th is information can be published if absolutely
necessary for scientific reasons and only after obtaining written
"informed consent" from the patient (or parents, or guardian).
The article must also state that "informed consent" was
obtained.
6.
RELATIONS WITH EDITOR(S), AUTHOR(S) AND
REFEREE(S)
Editors do not share information regarding articles (article
receipt, review process, referee opinions or final results) with
anyone except authors and referees. Referees and editorial board
members cannot discuss articles in a public manner. Editors
must send copies of the article to the editor once their review
is complete. Referee reviews cannot be printed or disclosed
without permission of the author and editor. Care is taken to
keep the identities of the referees. In some cases, the editor may
decide to send referee opinions on the article to other referees
reviewing the same article to inform them during the process.
All articles submitted will be subjected to peer-review by the
editorial board, and the authors will be informed within 6 weeks.
Editorial board reserves the right to make some revisions in the
article. Revised articles should also be accompanied by a unique
letter with responses to reviewers' comments. Articles that do
not comply with the journal requirements listed below may be
returned without review at the discretion of the editors.
7.
PREPARATION OF ARTICLE
Articles should be typed in 12 pt (Times New Roman), doublespaced
throughout with margins of 2.5 cm, and pages must be
numbered on the right upper corner. Manuscripts must be in
accordance with the International Committee of Medical Journal
Editors: Uniform Requirements for Manuscripts Submitted to
Biomedical Journals (
http://www.icmje.org/). Original articles
should not exceed 15 double spaced typewritten pages, and
case reports should not exceed 10 pages. Articles should be
typewritten in either "doc" or "txt" format and organized as
follows:
- Title page:
The title page should contain the article title,
authors' names and complete affiliations, a running title
not exceeding 40 characters and the address for manuscript
correspondence including e-mail address and telephone
and fax numbers. If the article was presented at a scientific
meeting, authors should provide a complete statement
including date and place of the meeting.
- Abstract and key words:
Original articles should contain
Turkish and English abstracts. Abstracts must be no
longer than 250 words. The structured abstract should
include objective, materials and methods, results and
conclusions in original articles. Case reports should also
include a structured abstract [objective, case report(s),
and conclusion]. Abbreviations should not be used in the
abstract.
The authors should list three to five key words or phrases
taken from Index Medicus Medical Subject Headings
(http://www.nlm.nih.gov/mesh/MBrowser.html).
- Text:
Original articles should be organized in four main
headings: introduction, materials and methods, results,
and discussion. Define abbreviations at first mention in the
text and in each table and figure. If a brand name is cited,
supply the manufacturer's name and address (city and
state/country). Case reports should include the following
identifiable sections: introduction, case report(s), and
discussion. An "acknowledgement(s)" section may be added
following these sections to thank those who helped the study
or preparation of the article, if any. The acknowledgements
are placed at the end of the article, before the references.
This section contains statements of gratitude for personal,
technical or material help, etc.
- References:
References should be provided at the end of the
article, under the title "References" and should be numbered
and listed according to their order in the text. They should be
referred to in parentheses within the text. Complete author
citation is required ("et al" is not acceptable). The author(s)
are responsible for the accuracy of the references. Journal
titles should be abbreviated according to Index Medicus.
Refer to the "List of Journals Indexed in Index Medicus" for
abbreviations of journal names, or access the list at
http://www.nlm.nih.gov/tsd/serials/lji.html. Abbreviations are not
used for journals not in the Index Medicus. Only published
articles or articles "in press" can be used in references.
Example of references are given below:
Journals:
Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson
CM, Phillips SC, Smith SK, Tavaré S, Print CG, Charnock-
Jones DS: Endometrial-peritoneal interactions during
endometriotic lesion establishment. Am J Pathol 2008,
173:700-715
Books:
Scheffler IE: Mitochondria. 2nd ed., New Jersey, Wiley-Liss, 2008, 417-436
Book chapters:
Ebstein JI: The Lower Urinary Tract and the Male Genital
Tract. In Kumar V, Abbas A, Fausto N. (Eds): Robbins and
Cotran Pathologic Basis of Disease. 7th ed., Philadelphia,
Elsevier Saunders, 2005, 1023-1058
On-line articles:
Abood S: Quality improvement initiative in nursing
homes: the ANA acts in an advisory role. Am J Nurs [serial
on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6).
Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm
- Tables:
Each table must be typed double-spaced on a separate
page following the references. Tables should be numbered
consecutively with Roman numerals in order of appearance
in the text and should include a short descriptive title typed
directly above and essential footnotes including definitions
of abbreviations below. They should be self-explanatory and
should supplement rather than duplicate the material in the
text.
- Figures:
All figures should be numbered sequentially in
the text with Arabic numbers and should be referred to in
parentheses within the text. Art should be created/scanned
and saved and submitted as either a TIFF or a JPEG file.
Electronic photographs, radiographs, CT scans, and
scanned images must have a resolution of at least 300 dpi. If
not obligatory any text typewritten on the figures should be
avoided.
- Figure legends:
Include legends for all figures. Legends
should appear on a separate page after the tables, should be
brief and specific, and should include magnification and the
stain used. Abbreviations and symbols used in the figures
must be denoted in the legend.
8.
SUBMISSION OF ARTICLES
All manuscripts must be submitted on-line through the web site
(
http://www.turkjpath.org/submit). A cover letter signed by all
authors should be faxed to "Buluş Tasarım ve Matbaacılık".
9.
REPRINTS
Authors will receive a complimentary electronic (PDF) reprint
of the article and a printed version of the journal. No hardcopy
complimentary reprints are provided by the publisher.
10.
COPYRIGHT
Copyright of an accepted article should be transferred to the
Federation of Turkish Pathology Societies. This transfer covers
the exclusive rights to reproduce and distribute the article.
Authors may make this published article available free on-line
provided that the source of the published article is cited and
the Federation of Turkish Pathology Societies is mentioned as
copyright holder in such a case, a link to the original article in
Turkish Journal of Pathology accompanied by the following
statement should also be created: "The original article is
available at
http://www.turkjpath.org". All articles published in
this journal are protected by copyright. No material published in
this journal may be reproduced in any forms without obtaining
written permission from the Federation of Turkish Pathology
Societies. The Federation of Turkish Pathology Societies does
not accept any legal responsibility for errors, omissions or claims
with respect to information published in the journal. Upon
acceptance of an article, "
Copyright Transfer Form" signed by
all authors should be faxed to "Buluş Tasarım ve Matbaacılık".
11.
EDITORIAL CORRESPONDENCE
Prof. Dr. Şükrü Oğuz Özdamar (Editor-in-Chief)
Zonguldak Karaelmas University, Medical Faculty,
Department of Pathology,
Esenköy-Kozlu, 67600, Zonguldak, Turkey
Tel : +90 (533) 381 55 32; +90 (372) 261 20 01 / 2442
Fax : +90 (372) 261 02 64
E-mail:
sukruoguzozdamar@yahoo.com
12.
PUBLISHER CORRESPONDENCE
Can Kangal (Manager)
Buluş Design and Printing
Bahriye Üçok Caddesi No: 9/1 Beşevler,
06500, Ankara, Turkey
Tel : +90 (312) 223 55 44 ; +90 (312) 222 44 06
Fax : +90 (312) 222 44 07
E-mail:
bulus@bulustasarim.com.tr